Kyverna Therapeutics autoimmun kasalliklar uchun hujayra terapiyalarini ishlab chiqayotgan klinik bosqichdagi biotexnologiya va farmatsevtika kompaniyasidir. Uning tadqiqotlari B hujayralari bilan bog‘liq kasalliklarni nishonga olish hamda uzoq muddatli, davolashsiz remissiyaga erishish imkoniyatini ko‘zlagan CAR T-hujayra yondashuvlariga qaratilgan. Kompaniyaning asosiy nomzod preparati KYV-101 ko‘p skleroz, miasteniya gravis, tizimli skleroz va qizil yugurik nefrit kabi kasalliklar bo‘yicha klinik sinovlarda baholanmoqda. Kyverna kompaniyasining ishlab chiqish dasturiga autoimmun kasalliklarni tadqiq etish va rivojlantirish ishlarini qo‘llab-quvvatlovchi autologik va allogenik CAR T-hujayra terapiyalari kiradi.
Vice President of Marketing, CAR-T Therapies — Remote, United States
Lead commercialization and launch strategy for Kyverna Therapeutics’ CAR-T portfolio in autoimmune diseases. Build the marketing organization and direct lifecycle expansion across multiple indications.
Amerika Qo‘shma Shtatlari320 000 $ – 350 000 $ / yil
MasofaviyTo‘liq stavkaYetakchiTalab Qilinadigan Til: inglizchaVitse-prezidentTavsif
- Lead commercial marketing for the company’s CAR-T portfolio across current and future autoimmune indications
- Shape the company-wide marketing strategy and commercial vision
- Build the strategic capabilities, infrastructure, and organizational readiness needed for growth
- Set launch objectives, customer priorities, positioning, messaging, channel plans, unbranded education, promotional strategy, and measurement approaches
- Convert clinical evidence, market research, competitive intelligence, and customer insights into actionable marketing plans
- Develop expertise in patient journeys, referral networks, treatment pathways, and adoption barriers across autoimmune diseases
- Guide the marketing organization through the company’s first product launch and create a repeatable launch framework
- Define launch performance measures and refine strategy using market feedback, customer behavior, competitive developments, and emerging data
- Create post-launch and differentiated lifecycle strategies for new indications, patient groups, and disease settings
- Work cross-functionally with Clinical Development, Medical Affairs, Market Access, Commercial Operations, Sales, Regulatory, and Legal/Compliance
- Build customer and market intelligence capabilities
- Bring commercial insight to senior leaders and the executive team
- Recruit and lead a high-performing marketing organization
- Identify the capabilities, talent, agency relationships, and infrastructure required for success
- Set objectives, operating practices, and performance measures
- Foster accountability, strategic thinking, collaboration, and agile execution
Talablar
- At least 15 years of progressively senior experience in biopharmaceutical commercial or marketing roles
- Substantial experience in specialty, rare disease, hematology, immunology, or other complex therapeutic markets
- A record of personally leading a successful U.S. product launch from pre-launch planning through commercialization
- Experience commercializing innovative therapies, ideally CAR-T, cell therapy, gene therapy, or similarly specialized treatments
- Demonstrated ability to develop multi-indication and lifecycle strategies for pharmaceutical or biotechnology assets
- Experience building or substantially transforming a marketing function within a growth-stage or emerging biotechnology company
- Strong knowledge of commercialization, brand strategy, market development, customer segmentation, personal and digital engagement, market research, forecasting, and promotion
- Ability to turn complex clinical and scientific evidence into differentiated commercial positioning
- Experience collaborating with Medical Affairs, Clinical Development, Market Access, Regulatory, Sales, and executive leadership
- Understanding of treatment, referral, reimbursement, and healthcare-provider ecosystems for specialty and cell therapies
- Knowledge of the challenges involved in launching innovative or highly specialized treatments
- Exceptional strategic judgment combined with a willingness to drive execution directly
- Outstanding communication skills and executive presence
- Ability to influence senior leaders and cross-functional partners
- Ability to succeed in a fast-moving, entrepreneurial environment with changing priorities
Imtiyozlar
- Eligibility for a bonus
- Employee benefits
- Participation in the company stock plan
- Remote work arrangement
- Approximately 25–40% travel